Warfarin abroad: the clinic that did not prescribe the drug is the one improvising around it

Let me concede the reassuring fact first, because it is true and patients deserve to hear it plainly. Most people on warfarin or other anticoagulants can have dental surgery safely, and for routine extractions the modern consensus generally leans toward continuing the drug with good local bleeding control rather than stopping it [1]. The reasoning is sound: interrupting an anticoagulant opens a gap in the protection it provides against stroke and clots, and for many patients that gap is more dangerous than any bleeding a socket would produce [1] [2]. So this is not a piece arguing that anticoagulated patients cannot travel for dental work, nor that warfarin makes surgery off-limits. It does neither.

The pivot is a question that the reassurance quietly assumes has already been answered: who is managing the anticoagulation around the procedure? At home, the answer is structural. Your warfarin is owned by a prescriber, often a GP or a dedicated anticoagulation clinic, who has monitored you for months or years, knows your usual INR range, and decides any perioperative change in conversation with your dentist. That ownership is the thing that makes “just continue the drug” a safe instruction rather than a guess. In the dental-tourism model, the clinic doing the surgery is frequently not the prescriber, has never seen your monitoring history, and ends up improvising around a regimen it does not own. The drug is the same. The management is not.

What “managing warfarin” actually means

It is easy to picture anticoagulation management as a single number to check on the morning of surgery. It is not. Warfarin is a drug with a narrow margin and a slow response, and managing it is an ongoing relationship rather than a one-off test [2]. The prescriber sets a target INR range based on why you are anticoagulated, watches how your individual body responds to a given dose, adjusts for interacting drugs and changes in diet, and tracks the trend over time. The point of all this is that any single INR value only means something against the background of your pattern.

The INR itself, derived from the prothrombin time, tells the clinician how prolonged your clotting currently is relative to a standard [3]. A value of around 1 corresponds to someone not taking warfarin, and higher values reflect stronger anticoagulation [2] [3]. That sounds like a clean, portable number, and it is precisely the kind of clean number that tempts a clinic into thinking the management travels with the patient. It does not. The number travels. The judgement about what the number means for you does not, because that judgement lives in the prescriber’s longitudinal view, not in a single morning’s blood draw.

The prescriber relationship is the safeguard, and it does not fly with you

At home, a perioperative anticoagulation decision is a short, almost invisible negotiation. The dentist identifies the bleeding risk of the planned procedure. The prescriber weighs that against your thrombotic risk and your INR stability. Together they decide whether to continue, hold, or, in selected higher-risk situations, bridge. Bridging means temporarily swapping the long-acting warfarin for a shorter-acting agent such as heparin around the procedure, so protection is maintained while the procedure-day anticoagulation is lowered, then warfarin is resumed afterward [4]. For most routine dental work, the answer is simply to continue with local measures, and bridging is reserved for specific circumstances [1] [4]. The key is that the answer is decided by the people who own the drug and your history.

WHO OWNS THE WARFARIN DECISION

  AT HOME                              ABROAD (one-trip model)
  -------                              -----------------------
  Prescriber / anticoagulation clinic  Surgical clinic did NOT prescribe
    owns the regimen                     the drug
        |                                       |
  Months/years of INR trend visible    One snapshot INR, no trend, no
        |                                  baseline to compare against
  Dentist contributes procedure              |
    bleeding risk                       Same clinic estimates bleeding
        |                                  risk AND makes the drug call
  Joint perioperative plan:                  |
    continue / hold / bridge           Improvised single-party decision,
        |                                  prescriber unreachable
  Prescriber resumes management and          |
    monitors the result afterward      Patient flies home; nobody who
                                          knows the regimen is watching

  The home model splits the decision across the people who hold the
  information. The tourism model collapses it into one party that
  holds almost none of it.

The diagram shows the actual failure, and it is not a failure of skill. A perfectly competent overseas surgeon is still the wrong party to be deciding your warfarin management, for the same reason a cardiologist is the wrong party to plan your extraction: they hold one half of the information and none of the other. When the clinic that did not prescribe the drug makes the perioperative call alone, it is improvising. It may improvise well. But “continue the warfarin,” which is the safe default at home precisely because a prescriber confirmed it against your history, becomes an unverified assumption when the same words are spoken by a clinic that has never seen your INR record and cannot reach the person who has.

The improvisations that should worry you most

There are two opposite errors, and the tourism setting can produce either. The first is the clinic that tells you to stop your warfarin a few days before surgery so the field is dry and easy. This feels intuitive to a patient and is often the more dangerous instruction, because it removes the protection the drug exists to provide and reintroduces clotting risk during the gap, with nobody monitoring you and no plan for resuming safely [1] [2]. A clinic that hands out a blanket “stop your blood thinner” instruction without reference to your prescriber is making a prescribing decision it has no standing to make.

The second error is subtler: the clinic that proceeds without genuinely engaging the anticoagulation at all, takes one INR, declares it acceptable, and operates. Here the snapshot problem bites. A single in-range reading does not tell the clinic whether you are normally stable or whether you swing, whether a recent dose change or a new interacting drug is about to move you, or whether today is typical [2] [3]. At home the prescriber would know. Abroad, the clinic is treating a stranger’s snapshot as if it were a managed trend. And the post-operative half is worse, because the period after surgery, when warfarin is resumed and the socket is healing, is the part most in need of ongoing management, and it is exactly the part the one-trip model abandons as you board the flight home.

The questions that change the answer

Because the danger lives in who is making the decision rather than in the drug itself, the questions that matter interrogate ownership and information, not the surgeon’s hands.

1. Has the clinic obtained a written perioperative anticoagulation plan from the doctor who actually prescribes and monitors my warfarin? This is the decisive question. A real plan names the drug, states whether it is continued, held, or bridged, and rests on your prescriber’s view of your stability and thrombotic risk. If the clinic intends to decide alone, the decision is being made by the party with the least information and no ability to monitor the result.

2. Does the clinic want to see my INR trend, or just a single reading on the day? This tests whether they understand what the number means. A clinic content with one snapshot is treating a value without its context. A clinic that asks for your recent INR history is at least trying to reconstruct the trend your prescriber would have used, though even that is a poor substitute for the prescriber’s actual judgement.

3. Who manages my anticoagulation after the surgery, once I have left the country? This exposes the abandoned half. Resuming warfarin safely, watching the early healing socket, and confirming the INR settles back into range are ongoing tasks. If the plan ends when you board the plane, the management has been delivered in halves, and the half that needs continuity has been left to nobody.

The bottom line

Most warfarin patients can have dental surgery safely, and I have kept that front and centre because it is true and because stopping the drug is often the more dangerous move. But the safety is not a property of the procedure or even of the drug. It is a property of who manages the anticoagulation around it. At home that is a prescriber who owns the regimen, sees your INR trend, knows why you are anticoagulated, and decides any perioperative change with your dentist, then resumes managing you afterward. In the one-trip tourism model, the clinic doing the surgery frequently did not prescribe the drug, sees one snapshot instead of a trend, makes the perioperative call alone, and is gone from your care the moment you fly. The same instruction, “continue the warfarin,” that is safe at home because a prescriber confirmed it against your history becomes an improvisation when spoken by a clinic that holds none of that history. If a clinic abroad proposes to change your anticoagulation without reference to the doctor who manages it, that is not reassurance. It is the clearest sign that the management this procedure depends on is being done by the wrong people.

For the distinct physiology of bleeding into a flight, see why a fresh extraction socket and a dry cabin expose the missing coordination. On other drug-history questions the intake form misses, see the one intake question that flags MRONJ risk, why osteoporosis drug history shadows a non-healing socket, and the drug-interaction void around overseas antibiotics. On the broader pattern of care delivered in halves, see when it makes sense to go overseas for dental treatment and the dental tourism trust gap. Our standing methodology and disclosures explain how these pieces are built.